Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.
The inhibitory and bactericidal activities of a novel cyclic peptide antibiotic, LY146032, and vancomycin against oxacillin-susceptible and oxacillin-resistant staphylococci were compared. The MICs for 90% of strains were two- to fourfold higher for vancomycin than for LY146032. MBC/MIC ratios for a...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1986
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180623/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3028254/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.6.938 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|